It is universally acknowledged that inflammatory cytokines are mediators of atherosclerosis, and previous studies have demonstrated that inflammatory genes can be regulated by STAT1–NF-κB or STAT1–IRF through over-expression in their promoters [26]. This evidence concerns the gene TRIM63 and atherosclerosis.